Summary
A patient developed severe neurological toxicity, with peripheral and cerebral components and hyponatraemia following one intrathecal injection of 80 mg cytosine arabinoside. The severity of his symptoms may reflect heavy prior neurotoxic chemotherapy.
Similar content being viewed by others
References
Athanassiou A, Begent RHJ, Newlands ES, Parker D, Rustin GJS, Bagshawe KD (1983) Central nervous system metastases of choriocarcinoma — 23 years experience at Charing Cross Hospital. Cancer 52: 1728
Brewer AC, Pitman SW, Dawson DM, Schoem WC (1977) Paraplegia following intrathecal cytosine arabinoside. Cancer 40: 2817
Goldberg ID, Bloomer WD, Dawson DM (1982) Nervous system toxic effects of cancer therapy. JAMA 247: 1437
Macauley VM, Begent RHJ, Phillips ME, Newlands ES (1983) Prophylaxis against hypomagnesaemia induced by cis-platinum combination chemotherapy. Cancer Chemother Pharmacol 9: 179
Mena H, Garcia JH, Velandia F (1981) Central and peripheral myelinopathy associated with systematic neoplasia and chemotherapy. Cancer 48: 1724
Newlands ES, Begent RHJ, Rustin GJS, Parker D, Bagshawe KD (1983) Further advances in the management of malignant teratomas of the testis and other sites. Lancet I: 948
Saiki JH, Thompson S, Smith S, Atkinson R (1972) Paraplegia following intrathecal chemotherapy. Cancer 29: 370
Winkelman MD, Hines JD (1983) Cerebral degeneration caused by high dose cytosine arabinoside. A clinicopathological study. Ann Neurol 14: 520
Wolff L, Zighelboim J, Gale RP (1979) Paraplegia following intrathecal cytosine arabinoside. Cancer 43: 83
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Crawford, S.M., Rustin, G.J.S. & Bagshawe, K.D. Acute neurological toxicity of intrathecal cytosine arabinoside. Cancer Chemother. Pharmacol. 16, 306–307 (1986). https://doi.org/10.1007/BF00293998
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00293998